Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA RegistryJorge Labrador, David Martínez‐Cuadrón, Blanca Boluda et al.|Cancer|2024Cited by 5
Final Results of Quiwi: A Double Blinded, Randomized Pethema Trial Comparing Standard Chemotherapy Plus Quizartinib Versus Placebo in Adult Patients with Newly Diagnosed <i>FLT3</i>-ITD Negative AMLPau Montesinos, Jorge Labrador, Víctor Noriega Concepción et al.|Blood|2024Cited by 5
Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemiaCatia Simoes, Patrik Fazio, Carmen González et al.|Blood Neoplasia|2024Cited by 2
Conventional PCR Versus Next Generation Sequencing for Diagnosis of <i>FLT3</i>, <i>IDH</i> and <i>NPM1</i> Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema GroupBlanca Boluda, Pau Montesinos, Claudia Sargas et al.|Blood|2022Cited by 1
Erratum: Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI StudyPau Montesinos, Jorge Labrador, Rebeca Rodríguez‐Veiga et al.|Journal of Clinical Oncology|2025Cited by 1